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Abstract In a proteomics-based screen for proteins interacting
with cyclin-dependent protein kinase (CDK), we have identi¢ed
a novel CDK complex containing the eukaryotic translation
initiation factor, eIF4A. Reciprocal immunoprecipitations using
antibodies against eIF4A indicate that the interaction is speci¢c.
The CDKA^eIF4A complex is abundant in actively proliferating
and growing cells but is absent from cells that have ceased
dividing. The CDKA^eIF4A complex contains kinase activity
that is sensitive to the CDK-speci¢c inhibitor roscovitine. This
interaction points to a possible molecular mechanism linking cell
proliferation with translational control.
( 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
Cyclin-dependent kinases (CDKs) are a family of serine/
threonine protein kinases that are involved in controlling
cell cycle progression. Their activity is modulated at a number
of levels including phosphorylation and binding to associated
regulatory proteins such as cyclins and low molecular weight
inhibitory proteins. Cyclins act as rate-limiting activating sub-
units that are produced and destroyed as necessary. Thus
di¡erent cyclins act at di¡erent points during the cell cycle :
broadly, D-type cyclins in G1/S phase and B-type cyclins in
G2/mitosis [1]. Cyclins are believed to target CDKs to speci¢c
substrates and thus di¡erentially control processes associated
with progression through the cell cycle.
A large number of cellular processes are di¡erentially regu-
lated during the cell cycle and it is not always clear that a
given process is directly regulated by CDK activity. One such
process is protein translation. The translation of transcripts
depends on the access of ribosomes to the mRNAs and the
eukaryotic translation initiation factor (eIF4) proteins facili-
tate and control such access; mRNA is recruited to the ribo-
some by the eIF4 complex that binds to the m7GpppX cap
present on the 5P end of most transcripts. eIF4-mediated
translation is dramatically reduced during mitosis in mamma-
lian cells and most protein translation ceases [2]. eIF4E is the
cap-binding component of eIF4, its function can be inhibited
by an eIF4E-binding partner (4E-BP). During mitosis 4E-BP
can be phosphorylated in vitro by human CDK1 [3], possibly
regulating the rate of translation. However, the 4E-BPs have
not yet been found in any plant genome, suggesting an alter-
native regulatory mechanism or that the function of 4E-BPs is
undertaken by a structurally divergent protein.
These associations between growth and translation suggest
a direct link between the cell cycle and the regulation of trans-
lation. Here we report a novel protein^protein interaction
between CDKA and eIF4A. We show that eIF4A can be
immunoprecipitated with CDKA and vice versa, that rosco-
vitine-sensitive histone H1 kinase activity precipitates with
eIF4A, and that the CDKA^eIF4A complex is most abundant
in actively proliferating cells.
2. Materials and methods
Arabidopsis cultures were maintained as described in [4]. Cells were
subcultured weekly into fresh Murashige and Skoog’s medium with
3% (w/v) sucrose, 0.5 mg/l NAA and 0.05 mg/l kinetin.
Extracts were prepared using a modi¢ed protocol from [5]. Protein
extracts were prepared by grinding 4-day-old Arabidopsis cells to a
¢ne powder in liquid nitrogen. The powder was resuspended in ‘ex-
traction bu¡er 1’ (50 mM Tris^HCl pH 8.0, 150 mM NaCl, 5 mM
EDTA, 5 mM NaF, 0.1% (v/v) Triton X-100) or in ‘extraction bu¡er
2’ for kinase assays (25 mM Tris^HCl pH 8.0, 10 mM MgCl2, 15 mM
EGTA, 75 mM NaCl, 1 mM dithiothreitol (DTT), 1 mM NaF, 0.5
mM Na3VO4, 15 mM L-glycerophosphate, 15 mM 4-nitrophenylphos-
phate, 0.1% (v/v) Tween-20, 0.5 mM PMSF, 5 Wg/ml leupeptin, 5 Wg/
ml aprotinin). The mixture was centrifuged (18 000Ug, 20 min) and
then used for immunoprecipitation.
For immunoprecipitations, 7m-GTP Sepharose and p13suc1 a⁄nity
puri¢cation, protein extracts were added onto 40 Wl of protein G
beads (Sigma) with 5^20 Wl of antibody or 7m-GTP Sepharose (Amer-
sham) or p13suc1 beads made as described [6]. This mixture was incu-
bated at 4‡C overnight. The beads were washed four times with bead
bu¡er (50 mM Tris^HCl p H8.0, 150 mM NaCl, 5 mM EGTA, 5 mM
NaF, 0.01% (v/v) NP-40). The proteins were eluted from the beads
with Laemmli sample bu¡er and boiled for 5 min.
Kinase assays were performed using a protocol modi¢ed from [5].
Immunoprecipitations were performed as above, except the protein G
beads were washed with kinase wash bu¡er (20 mM HEPES pH 7.5,
15 mM MgCl2, 5 mM EGTA, 1 mM DTT). Once washed the beads
were incubated for 30 min in kinase wash bu¡er supplemented with 74
kBq 32P[ATP], 10 mM ATP, 1 mg/ml histone H1 (GibcoBRL). The
reaction was stopped with the addition of Laemmli sample bu¡er.
Final extracts were run on 12.5% SDS^PAGE gels and radioactive
incorporation was detected using X-OMAT ¢lm (Kodak).
Proteins were identi¢ed from gels by mass spectrometry (MS) as
described previously [7].
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3. Results
3.1. eIF4A interacts in vivo with CDKA
CDKA was immunoprecipitated (Fig. 1) using an antibody
directed to the PSTAIRE region of CDKA (anti-PSTAIRE,
Sigma), anti-CDKA and anti-cyclin D3 [8] (both gifts from
J.A.H. Murray). Mouse IgG and a blank immunoprecipita-
tion without antibody were used as controls. Anti-PSTAIRE
and anti-CDKA speci¢cally precipitate CDKA, as determined
by Western blotting (Fig. 1B) and anti-cyclin D3 co-precipi-
tates CDKA as previously described [8]. A band correspond-
ing to the predicted molecular weight of CDKA (Fig. 1A,
closed arrow) was excised from the gel, cleaved using trypsin
and the fragments analysed by MS as previously described [7].
The MS ¢ngerprint contained eleven tryptic fragments that
matched to predicted tryptic fragments of Arabidopsis CDKA
(tolerance set to 50 ppm), con¢rming the identity of CDKA.
Another major band at about 45 kDa, marked with an open
arrow, was also analysed by MS identi¢cation of peptide
fragments. The resulting mass ¢ngerprints corresponded to
Arabidopsis AteIF4A1 or AteIF4A2 as potential proteins
present in that location of the gel. AteIF4A1 and AteIF4A2
are extremely similar, sharing 96% similarity at the amino acid
level [9] and thus they could not be di¡erentiated by the MS
¢ngerprint.
To con¢rm the speci¢city of this interaction we used eIF4A
antibodies to carry out a reciprocal immunoprecipitation and
tested for the presence of CDKA. The eIF4A antibody (gift of
C. Kuhlemeier) was raised against a tobacco protein so we
¢rst tested the speci¢city of the anti-eIF4A antibody on Ara-
bidopsis extracts. Fig. 2A shows a Western blot of Arabidopsis
and tobacco whole cell extracts probed with the eIF4A anti-
body. This antibody blots a doublet in tobacco, in agreement
with [10], and cross-reacts with a single band in Arabidopsis
whole cell extracts. The band recognised by the antibody in
Arabidopsis extracts has the predicted molecular weight for
eIF4A proteins (AteIF4A1 and AteIF4A2 which are both
47 kDa). This antibody was then used to probe the CDKA
immunoprecipitations originally used to identify eIF4A by
MS. In this way, we con¢rmed the presence of eIF4A in the
anti-PSTAIRE immunoprecipitation and showed that it is
absent in both controls, immunoprecipitation with mouse
Fig. 1. CDKA complexes contain eIF4A. A: Silver stained 10% gel
of immunoprecipitations from extracts of 4-day-old Arabidopsis cells
using the following antibodies: (1) anti-PSTAIRE, (2) anti-CDKA,
(3) anti-cyclin D3, (4) mouse IgG and (5) protein G beads only (no
antibody). Closed arrow ^ CDKA location. Open arrow ^ protein
band identi¢ed as eIF4A by MS. B: Western blot of the gel shown
in panel A, probed with anti-PSTAIRE antibody.
Fig. 2. eIF4A complexes contain an active CDKA. A: Arabidopsis
and tobacco whole cell extracts were probed with anti-eIF4A. B:
Western blot probed with anti-eIF4A. Lanes: (1) whole cell extract
before immunoprecipitation, (2) immunoprecipitation with anti-
PSTAIRE, (3) immunoprecipitation with mouse IgG and (4) protein
G beads only (no antibody). C: A reciprocal immunoprecipitation;
eIF4A was immunoprecipitated and probed for co-precipitating
CDKA. The lower bands in lanes 2 and 3 correspond to the light
chain of IgG. D: Histone H1 kinase assays were performed on pro-
tein extracts from 4-day-old Arabidopsis cells. Kinase activity was
puri¢ed using p13suc1, anti-CDKA, anti-cyclin D3 and anti-eIF4A.
Increasing concentrations of the CDKA inhibitor roscovitine were
added to the kinase reaction as indicated. E: 7m-GTP Sepharose
can co-precipitate eIF4A. Lanes: (1) whole cell extract before immu-
noprecipitation, (2) precipitation with 7m-GTP Sepharose beads and
(3) with Sepharose 4B beads. The eluted proteins were probed for
the presence of eIF4A. F: CDKA is not a member of the mRNA
cap-binding complex. Lanes: (1) whole cell extract before immuno-
precipitation, (2) immunoprecipitation with anti-PSTAIRE, (3) with
anti-CDKA, (4) with 7m-GTP-Sepharose, (5) p13suc1, (6) mouse IgG
and (7) no antibody. The eluted proteins were probed for the pres-
ence of CDKA with anti-PSTAIRE antibody. The lower band cor-
responds to the light chain of IgG.
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IgG and without antibody (Fig. 2B, lanes 3 and 4). Finally,
we performed a reciprocal immunoprecipitation using the
anti-eIF4A antibody to immunoprecipitate eIF4A and then
used Western blotting to determine if CDKA co-precipitates.
Fig. 2C shows that CDKA is present in the anti-eIF4A im-
munoprecipitations, con¢rming the interaction.
Next, we measured the histone H1 kinase activity associated
with eIF4A and compared this to the total kinase activity as
isolated by other methods. In Fig. 2D, p13suc1 pellets the
maximal histone H1 kinase activity, probably representing
multiple CDK-related complexes. The anti-CDKA pellet has
less kinase activity than p13suc1 precipitates, and is consider-
ably more sensitive to the CDKA-speci¢c inhibitor roscovi-
tine. The p13suc1 precipitate requires in excess of 5 WM rosco-
vitine for inhibition, suggesting the presence of diverse
kinases, whereas the anti-CDKA-associated kinase activity is
sensitive to only 0.5 WM roscovitine, suggesting a smaller pool
of more speci¢c kinase. In all of the experiments the selective
CDKA inhibitor roscovitine was used to determine the activ-
ity of CDKA as opposed to other histone H1 kinases. The
anti-cyclin D3 antibody precipitates only CDKA activity
bound to cyclin D3 [8], and reveals a signi¢cantly lower kinase
activity re£ecting the fact that the antibody targets a single
cyclin and therefore precipitates a small subpool of CDKA
kinase activity. Anti-eIF4A also precipitates roscovitine-sensi-
tive histone H1 kinase activity. Anti-eIF4A isolates a smaller
amount of kinase activity compared to that precipitated by
p13suc1 or anti-CDKA, but is comparable to that isolated by
anti-cyclin D3.
To test if CDKA is a component of the eIF4F mRNA cap-
binding complex, we isolated the cap complex from cell ex-
tracts using 7m-GTP Sepharose beads. Sepharose 7m-GTP is
commonly used to purify the eIF4F complex [9,11^13]. We
found that eIF4A could be intermittently detected by Western
blot (Fig. 2E). However, CDKA was never detected bound to
7m-GTP beads, whether eIF4A was present or not (Fig. 2F).
3.2. CDKA and eIF4A interact in proliferating cells
Both CDKA and eIF4A are constitutively expressed in
both proliferating and non-proliferating cells [9,14] (Fig.
3A), but their function is regulated by phosphorylation, pro-
tein localisation and protein^protein interactions. Therefore,
we examined if and how the interaction between CDKA and
eIF4A changed during the growth cycle. Over the course of
eight days the Arabidopsis culture goes through a character-
istic growth cycle [8,15] : a lag phase before day 1, followed by
an exponential growth phase from days 2 to 4, then a cessa-
tion of cell division and an increase in biomass from days 5 to
7. Finally, after day 7, the cell enters stationary phase.
For each day we prepared protein extracts and performed
an anti-PSTAIRE immunoprecipitation on those extracts.
Fig. 3A shows Western blots on the whole cell extracts prior
to immunoprecipitation. The amount of CDKA (anti-
PSTAIRE) remains constant for the ¢rst 4 days and then
declines slightly, cyclin D2 is constant from days 2 to 4, before
becoming undetectable as the mitotic index of the culture
declines. Despite this decline in mitosis the eIF4A protein
remains at a constant level from days 2 through 7, suggesting
that the regulation of eIF4A function is post-translational.
When CDKA was immunoprecipitated (Fig. 3B) a constant
amount of CDKA was precipitated from days 2 through 7.
However, the amount of eIF4A co-precipitating with CDKA
between days 2 and 5 varied with the age of the cell culture;
as the cell began to exit the cell cycle around day 5 the
amount of CDKA^eIF4A declined and was undetectable at
day 6.
4. Discussion
Here we show that CDKA physically interacts with eIF4A
in vivo. This is based on reciprocal immunoprecipitations us-
ing antibodies against eIF4A and CDKA. Furthermore, im-
munoprecipitation of eIF4A co-precipitates histone H1 kinase
activity that is sensitive to the speci¢c CDKA inhibitor rosco-
vitine, indicating that the CDKA^eIF4A complex contains an
active kinase. In addition, the interaction is associated with
cell proliferation since it can no longer be detected late in the
growth cycle when cells cease growing.
There is a considerable body of evidence that growth and
cell proliferation are tightly linked with translation but the
molecular basis of this linkage is uncertain. Translation and
growth may be coupled through the eIF4E subunit, primarily
through the action of mTOR and p70s6 kinases [16]. CDKA
has been implicated in the regulation of cap-dependent trans-
lation, phosphorylating and activating the inhibitory protein
4E-BP [3]. However, the 4E-BPs have not been found in plant
genomes [9], so it is unclear if this form of translational reg-
ulation exists in plants.
Anti-eIF4A precipitates histone H1 kinase activity that can
be inhibited by the CDKA inhibitor roscovitine. The level of
kinase activity and its roscovitine sensitivity was very similar
to that of the cyclin D-associated kinase, suggesting that
CDKA bound to eIF4A represents a small subpool of the
total CDKA activity. That histone H1 kinase activity co-pre-
cipitates with eIF4A indicates that eIF4A bound CDKA is
active and may phosphorylate eIF4A; eIF4A does contain a
potential CDKA phosphorylation site and eIF4A is known to
be phosphorylated in plants in response to various stimula-
tions [17,18]. However, the identity of the kinase responsible
and the phosphorylated sites remain unknown.
Anti-PSTAIRE does not co-precipitate an active CDKA
Fig. 3. The CDKA^eIF4A interaction varies during the growth
cycle. A: Western blots of whole cell extracts prepared daily from
Arabidopsis cells were probed with anti-PSTAIRE, anti-cyclin D2
and anti-eIF4A to detect the levels of CDKA, cyclin D2 and eIF4A
respectively. The percentage of cells in mitosis (mitotic index) for
that particular day is shown beneath each lane. B: The protein ex-
tracts from panel A were subjected to anti-PSTAIRE immunopreci-
pitations and the precipitated proteins were probed for the presence
of CDKA (using an anti-PSTAIRE antibody) and eIF4A. Whole
cell extract was used to indicate the position of CDKA and eIF4A
on the Western blots.
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complex (data not shown), as the anti-PSTAIRE antibody is
thought to interfere with cyclin binding [19]. However, precip-
itation of active histone H1 kinase activity using an anti-
eIF4A antibody suggests that the CDKA is bound to an as
yet unknown cyclin. The ¢rst outcome of these observations is
that CDKA can bind to eIF4A independently of a cyclin,
possibly binding through unknown intermediate proteins.
The nature and identity of the cyclin remains unknown. De-
termining the identity of the cyclin would provide valuable
clues as to the cell cycle phase-speci¢c activity of the
CDKA^eIF4A complex.
This study demonstrates that the eIF4A^CDKA complex is
present in cells that are rapidly dividing and growing. The
complex becomes less abundant as the cells switch from a
phase characterised by small cycling cells, to one marked by
a decrease of the mitotic index and a rise in cell expansion at
about day 5. Despite this drop in mitotic index the biomass of
the cells in the expansion phase continues to increase dramat-
ically. This indicates that the interaction occurs only in pro-
liferating cells and is not required for cell expansion. Our
work suggests that eIF4A may be part of a complex that
targets CDKA to the translation machinery.
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